Target intelligence / Profile preview

Protein phosphatase 1 regulatory inhibitor subunit 14B (PPP1R14B)

Target
PPP1R14B
Molecular classification
Other (regulatory protein), Enzyme inhibitor (serine/threonine phosphatase inhibitor)
01

Overview

Protein phosphatase 1 regulatory inhibitor subunit 14B (PPP1R14B, also known as PHI-1) is a regulatory protein that functions as a potent inhibitor of protein phosphatase 1 (PP1, specifically the catalytic subunit PPP1CA), with over 50-fold higher inhibitory activity when phosphorylated[2][3]. It plays essential roles in regulating the cell cycle, apoptosis, and actomyosin contractility. PPP1R14B is strongly expressed in various tumor types and is associated with poor prognosis in cancer. Its expression correlates with immune cell infiltration (notably myeloid-derived suppressor cells) and pathways including cell cycle and RNA processing, suggesting fundamental roles in cancer progression and immune regulation. PPP1R14B serves as a prognostic biomarker in several malignancies and is being explored as an antitumor target, but no approved drugs are known to directly interact with or target this protein[1][2][3][5].

Other names
PHI-1phosphatase holoenzyme inhibitor 1PLCB3NPNGSOM172Phospholipase C beta-3 neighboring gene protein
02

Mechanism of action

Inhibits protein phosphatase 1 (PPP1CA) activity, especially when phosphorylated[2][3]

03

Biological functions

Signal transductionCell cycle regulationInnate immune responseApoptosisRNA processing
04

Disease associations

Cancer, especially pan-cancer biomarker (including ovarian clear cell carcinoma, prostate cancer, chronic lymphocytic leukemia)Potential role in immune-related diseases
05

Safety considerations

No specific direct therapeutic safety data identified; potential concern from broad involvement in cell cycle and immune regulation could imply risks if therapeutically targeted
06

Biomarkers

Prognostic biomarker for pan-cancer (associated with poor survival, immune infiltration, and tumor microenvironment characteristics)[1]

Beyond the preview

Go deeper on Protein phosphatase 1 regulatory inhibitor subunit 14B (PPP1R14B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein phosphatase 1 regulatory inhibitor subunit 14B (PPP1R14B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call